Drug company merger should benefit research

被引：0

作者：

Labreque, G

机构：

来源：

BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7130期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：494 / 494

页数：1

共 50 条

[21] FAILING FAILING COMPANY JUSTIFICATION FOR A MERGER
BOCK, B
CONFERENCE BOARD RECORD, 1969, 6 (06): : 26 - 31
[22] Merger creates giant services company
不详
ASHRAE JOURNAL, 2000, 42 (04) : 12 - 12
[23] THE MERGER - BACKGROUND BRIEFING - AMCOR - THE COMPANY
不详
APPITA JOURNAL, 1993, 46 (06): : 400 - 401
[24] Empirical Research of Merger and Acquisition Performance on China's Media Industry Listed Company
Zou Xiuling
PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON MODERN MANAGEMENT, EDUCATION TECHNOLOGY, AND SOCIAL SCIENCE (MMETSS 2016), 2016, 91 : 215 - 224
[25] Company performance before and after a merger
Beverly, C.
Sutejo, B. S.
Murhadi, W. R.
PROCEEDINGS OF THE 16TH INTERNATIONAL SYMPOSIUM ON MANAGEMENT (INSYMA 2019), 2019, 308 : 28 - 31
[26] German sugar company merger confirmed
不详
ZUCKERINDUSTRIE, 1997, 122 (09): : 689 - 689
[27] Disaster-zone research: participants should benefit too
Tomoyuki Kobayashi
Yoshitake Takebayashi
Michio Murakami
Nature, 2020, 579 (7798) : 193 - 193
[28] Our Measure of Medical Research Should Be Appreciable Benefit to the Patient
Lubowitz, James H.
Brand, Jefferson C.
Rossi, Michael J.
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2019, 35 (07): : 1943 - 1944
[29] The Benefit of Seeing in Company
Apperly, Ian A.
TRENDS IN COGNITIVE SCIENCES, 2019, 23 (06) : 451 - 453
[30] The public benefit standard for merger authorisations
King, Stephen P.
AUSTRALIAN BUSINESS LAW REVIEW, 2006, 34 (01): : 38 - 48